Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
ephedrinhydrochlorid 3 mg/ml injektionsvæske, opløsning, ampul a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 30 mg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 3 mg/ml injektionsvæske, opløsning i fyldt injektionssprøjte a 10 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride [respiratory use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 15 mg/5 ml eliksir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 4 mg/5 ml sukkerfri mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine HCl [enuresis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride [nose] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 10 mg/mL nasal drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 6,25 mg + guaifenesin 100 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine sulfate 2.5 mg/mL nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid 8 mg + kaliumiodid 150 mg syrup |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
ephedrinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
|
Ephedrine hydrochloride 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 15 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 30 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 15 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 30 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 11 mg and theophylline 120 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
2 |
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 800 microgram/1 milliliter conventional release oral solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 800 microgram/1 milliliter conventional release oral solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 3 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 3 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 10 mg/mL nasal drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 10 mg/mL nasal drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 5 milligram/1 milliliter conventional release nasal drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 30 milligram/1 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 30 milligram/1 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely ephedrine hydrochloride 30 milligram/10 milliliter conventional release solution for injection ampule |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 30 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 30 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 3 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Ephedrine hydrochloride 3 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Ephedrine hydrochloride (substance) |
Inferred relationship |
Some |
1 |